BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 31175048)

  • 1. Clinical Outcomes of Sentinel Cerebral Protection System Use During Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ndunda PM; Vindhyal MR; Muutu TM; Fanari Z
    Cardiovasc Revasc Med; 2020 Jun; 21(6):717-722. PubMed ID: 31175048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral embolic protection during transcatheter aortic valve replacement: a systematic review and meta-analysis of propensity score matched and randomized controlled trials using the Sentinel cerebral embolic protection device.
    Wolfrum M; Handerer IJ; Moccetti F; Schmeisser A; Braun-Dullaeus RC; Toggweiler S
    BMC Cardiovasc Disord; 2023 Jun; 23(1):306. PubMed ID: 37330463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Significantly Reduces Death and Stroke Compared With Unprotected Procedures.
    Seeger J; Gonska B; Otto M; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2297-2303. PubMed ID: 28917515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cerebral protection devices in transcatheter aortic valve replacement: A clinical end-points meta-analysis.
    Mohananey D; Sankaramangalam K; Kumar A; Jobanputra Y; Villablanca P; Krishnaswamy A; Mick S; Svensson LG; Tuzcu EM; Kapadia SR
    Cardiovasc Revasc Med; 2018 Oct; 19(7 Pt A):785-791. PubMed ID: 29550047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement.
    Van Gils L; Kroon H; Daemen J; Ren C; Maugenest AM; Schipper M; De Jaegere PP; Van Mieghem NM
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):790-797. PubMed ID: 28895285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of routine use of a cerebral protection device on the TAVR procedure and its short-term outcomes: a single-centre experience.
    von Kemp MJ; Floré V; Lau CW; De Sutter J; Provenier F; Cornelis K
    Acta Cardiol; 2022 Dec; 77(10):922-929. PubMed ID: 36044035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Outcomes With Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Giustino G; Mehran R; Veltkamp R; Faggioni M; Baber U; Dangas GD
    JACC Cardiovasc Interv; 2016 Oct; 9(20):2124-2133. PubMed ID: 27765306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral protection devices during transcatheter aortic valve implantation.
    Vlastra W; Vendrik J; Koch KT; Baan J; Piek JJ; Delewi R
    Trends Cardiovasc Med; 2018 Aug; 28(6):412-418. PubMed ID: 29428159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral embolic protection systems for transcatheter aortic valve replacement.
    Gasior T; Mangner N; Bijoch J; Wojakowski W
    J Interv Cardiol; 2018 Dec; 31(6):891-898. PubMed ID: 30467892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Debris Heterogeneity Across Different Valve Types Captured by a Cerebral Protection System During Transcatheter Aortic Valve Replacement.
    Schmidt T; Leon MB; Mehran R; Kuck KH; Alu MC; Braumann RE; Kodali S; Kapadia SR; Linke A; Makkar R; Naber C; Romero ME; Virmani R; Frerker C
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1262-1273. PubMed ID: 29976363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement.
    Latib A; Mangieri A; Vezzulli P; Spagnolo P; Sardanelli F; Fellegara G; Pagnesi M; Giannini F; Falini A; Gorla R; Montorfano M; Bedogni F; Colombo A; Popma J; Merhi WM; De Marco F
    JACC Cardiovasc Interv; 2020 Apr; 13(7):860-868. PubMed ID: 32273098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-World Experience of the Sentinel Cerebral Protection Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database.
    Case BC; Forrestal BJ; Yerasi C; Khan JM; Khalid N; Shlofmitz E; Chen Y; Musallam A; Chezar-Azerrad C; Satler LF; Ben-Dor I; Rogers T; Waksman R
    Cardiovasc Revasc Med; 2020 Feb; 21(2):235-238. PubMed ID: 31780421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcarotid transcatheter aortic valve replacement with cerebral embolic protection.
    McGrath D; Salehi P; Weintraub A; Zhan Y
    J Card Surg; 2022 Jun; 37(6):1779-1782. PubMed ID: 35301761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significant Differences in Debris Captured by the Sentinel Dual-Filter Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement Among Different Valve Types.
    Seeger J; Virmani R; Romero M; Gonska B; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1683-1693. PubMed ID: 30154060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement.
    Voss S; Deutsch MA; Schechtl J; Erlebach M; Sideris K; Lange R; Bleiziffer S
    Thorac Cardiovasc Surg; 2020 Oct; 68(7):616-622. PubMed ID: 31091551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome of Transcatheter Aortic Valve Replacement With TriGUARD 3™ Cerebral Embolic Protection Device.
    Daal SM; Jimenez-Rodriguez GMJ; Voskuil M; Kraaijeveld AO; Dessing TC; Ramjankhan FZ; Mokhles MM; Stella PR
    Cardiovasc Revasc Med; 2023 May; 50():8-12. PubMed ID: 36681530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Clinical Impact of Cerebral Embolic Protection in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Kroon HG; van der Werf HW; Hoeks SE; van Gils L; van den Berge FR; El Faquir N; Rahhab Z; Daemen J; Poelman J; Schurer RAJ; van den Heuvel A; de Jaegere P; van der Harst P; Van Mieghem NM
    Circ Cardiovasc Interv; 2019 Jun; 12(6):e007605. PubMed ID: 31195822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebral embolic protection during transcatheter aortic valve replacement: Insights from a consecutive series with the Sentinel cerebral protection device.
    Wolfrum M; Moccetti F; Loretz L; Bossard M; Attiger A; Cuculi F; Toggweiler S
    Catheter Cardiovasc Interv; 2023 Aug; 102(2):339-347. PubMed ID: 37232417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of transcatheter aortic valve replacement in aortic stenosis patients at low to moderate surgical risk: a comprehensive meta-analysis.
    Elmaraezy A; Ismail A; Abushouk AI; Eltoomy M; Saad S; Negida A; Abdelaty OM; Abdallah AR; Aboelfotoh AM; Hassan HM; Elmaraezy AG; Morsi M; Althaher F; Althaher M; AlSafadi AM
    BMC Cardiovasc Disord; 2017 Aug; 17(1):234. PubMed ID: 28836953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral Embolic Protection and Stroke-Related Mortality Following Transcatheter Aortic Valve Replacement.
    Isogai T; Bansal A; Vanguru HR; Agrawal A; Shekhar S; Puri R; Reed GW; Krishnaswamy A; Uchino K; Kapadia SR
    JACC Cardiovasc Interv; 2022 Mar; 15(5):569-571. PubMed ID: 35272784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.